FDA Permits Marketing of Brain Stimulation Device for OCD
FRIDAY, Aug. 17, 2018 -- A brain stimulation device to treat obsessive-compulsive disorder (OCD) has received approval for marketing by the U.S. Food and Drug Administration.
Transcranial magnetic stimulation uses magnetic fields to stimulate nerve...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Brain | Food and Drug Administration (FDA) | Marketing | Neurology | Obsessive Compulsive Disorder | Pharmaceuticals